EternoGen

About:

EternoGen is a medical biotech company designing and manufacturing collagen scaffolds for soft tissue therapeutic applications.

Website: http://eternogen.com

Twitter/X: eternogen

Top Investors: Arch Grants, Missouri Technology Corporation, Centennial Investors, Allen Angel Capital Education Program (AACE), University of Missouri Enterprise Investment Program

Description:

EternoGen is a medical biotech company designing and manufacturing collagen scaffolds for soft tissue therapeutic applications. It is primarily a research and development company that utilizes expertise in clinical market evaluation, material science, and biological engineering to execute its clinical development model. The company was founded in 2009 and is headquartered in Columbia, Missouri.

Total Funding Amount:

$9.69M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Columbia, Missouri, United States

Founded Date:

2009-01-01

Founders:

Anna Tenstam Lundvall, Anthony Harris, Dave Grant, Dave Grant, Sheila Grant

Number of Employees:

1-10

Last Funding Date:

2016-06-28

IPO Status:

Private

Industries:

© 2025 bioDAO.ai